יחס מחיר לרווח CoDx (CODX)
The market value of Co-Diagnostics, Inc. (CODX) on the GURU.Markets platform, where the PE ratio stands at -0.10, as illustrated on this chart, characterizes the health diagnostics business. Co-Diagnostics, Inc. (CODX) remains resilient to market volatility, leveraging the success of new products and tests. Proprietary rights to CoPrime and strict FDA oversight create a high barrier to entry. Additionally, the firm is implementing green packaging and energy efficiency to comply with ESG standards.
פילוחים אנליטיים של חברת Co-Diagnostics, Inc.
Institutional capital assesses the investment attractiveness of Co-Diagnostics, Inc. (CODX) through the price-to-earnings ratio, which determines the payback period for investments in the molecular diagnostics business. By analyzing the P/E ratio based on net income, investors can see how the diversification of PCR tests for the medical and agricultural sectors impacts fundamental value, confirming the asset's resilience amid price volatility.
